Abstract
A clinical decision report using:
Hals IK, Fiskvik Fleiner H, Reimers N, et al. Investigating optimal β-cell-preserving treatment in latent autoimmune diabetes in adults: Results from a 21-month randomized trial. Diabetes Obes Metab. 2019;21(10):2219-2227. https://doi.org/10.1111/dom.13797
for a patient with an aversion to needles.
DOI
10.22237/crp/1640995620
Creative Commons License
This work is licensed under a Attribution 4.0 International (CC-BY 4.0) License
Recommended Citation
NASSER S. Insulin therapy versus oral sitagliptin for treatment of latent autoimmune diabetes in adults. Clin. Res. Prac. Apr 28 2022;8(1):eP2634. https://doi.org/10.22237/crp/1640995620
COinS
